SEATTLE — Molecular testing has been widely integrated into mainstream healthcare, and its use is increasing in dermatology. It can help differentiate between skin conditions, for example, as some ...
cobas 5800 is a new compact addition to the Roche molecular diagnostics portfolio that provides a scalable, high performance testing solution for labs of all sizes. Infectious diseases, such as HIV, ...
Certain serious fungal infections occur in regions of the United States with specific environments and are often tied to soil exposure. These infections can affect both healthy and immunocompromised ...
In 2021, only 6.4 million of the 10.6 million people with tuberculosis (TB) were diagnosed and treated for the disease. Although the World Health Organization recommends initial diagnostic testing ...
Before testing new therapies in animals, researchers now have a more efficient starting point—lab-grown canine muscle cells ...
Please provide your email address to receive an email when new articles are posted on . Precision medicine has shown great potential to improve treatment outcomes and prolong survival of patients with ...
Hosted on MSN
Insight Molecular Diagnostics outlines $1B transplant testing market expansion as company nears FDA submission
Earnings Call Insights: Insight Molecular Diagnostics Inc. (IMDX) Q3 2025 CEO Joshua Riggs highlighted that Insight Molecular Diagnostics is nearing a transformative milestone, stating, "In 2026, with ...
The global Urinary Tract Infection Testing Market is entering a period of sustained expansion as healthcare systems ...
Insight Molecular Diagnostics Inc. (NASDAQ:IMDX) is one of the high-growth micro-cap stocks to buy now. On June 11, Insight ...
The SARS-CoV-2 pandemic led to unprecedented testing demands, causing major testing delays globally. One strategy used for increasing testing capacity was pooled-testing, using a two-stage technique ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results